Vadadustat Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

It is formulated by 1 pharmaceutical company such as AKEBIA. It is marketed under 1 brand name, including VAFSEO. Available in 3 different strengths, such as 150MG, 300MG, 450MG, and administered through 1 route including TABLET;ORAL.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 1 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"18288","ingredient":"VADADUSTAT","trade_name":"VAFSEO","family_id":"cd6280c81d0f447cbe9a","publication_number":"USRE47437E","cleaned_patent_number":"RE47437","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-06-26","publication_date":"2019-06-18","legal_status":"Granted"} USRE47437E1 Molecular Formulation 18 Jun, 2019 Granted 26 Jun, 2027
{"application_id":"18265","ingredient":"VADADUSTAT","trade_name":"VAFSEO","family_id":"cd6280c81d0f447cbe9a","publication_number":"US8940773B2","cleaned_patent_number":"8940773","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-06-26","publication_date":"2015-01-27","legal_status":"Patented case"} US8940773B2 27 Jan, 2015 Patented case 26 Jun, 2027
{"application_id":"18298","ingredient":"VADADUSTAT","trade_name":"VAFSEO","family_id":"cd6280c81d0f447cbe9a","publication_number":"US8598210B2","cleaned_patent_number":"8598210","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-06-26","publication_date":"2013-12-03","legal_status":"Granted"} US8598210B2 Molecular Formulation 03 Dec, 2013 Granted 26 Jun, 2027
{"application_id":"18272","ingredient":"VADADUSTAT","trade_name":"VAFSEO","family_id":"cd6280c81d0f447cbe9a","publication_number":"US8343952B2","cleaned_patent_number":"8343952","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-08-14","publication_date":"2013-01-01","legal_status":"Granted"} US8343952B2 Molecular Formulation 01 Jan, 2013 Granted 14 Aug, 2027
{"application_id":"18300","ingredient":"VADADUSTAT","trade_name":"VAFSEO","family_id":"cd6280c81d0f447cbe9a","publication_number":"US7811595B2","cleaned_patent_number":"7811595","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-03-13","publication_date":"2010-10-12","legal_status":"Granted"} US7811595B2 Molecular Formulation 12 Oct, 2010 Granted 13 Mar, 2028
{"application_id":"18277","ingredient":"VADADUSTAT","trade_name":"VAFSEO","family_id":"cd6280c81d0f447cbe9a","publication_number":"US8323671B2","cleaned_patent_number":"8323671","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-04-03","publication_date":"2012-12-04","legal_status":"Granted"} US8323671B2 04 Dec, 2012 Granted 03 Apr, 2028
{"application_id":"36586","ingredient":"VADADUSTAT","trade_name":"VAFSEO","family_id":"8098bc4b51fa4612863f","publication_number":"US11857543B2","cleaned_patent_number":"11857543","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-06-09","publication_date":"2024-01-02","legal_status":"Granted"} US11857543B2 02 Jan, 2024 Granted 09 Jun, 2034
{"application_id":"18592","ingredient":"VADADUSTAT","trade_name":"VAFSEO","family_id":"e14e7118e981465fa4fa","publication_number":"US9987262B2","cleaned_patent_number":"9987262","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-14","publication_date":"2018-06-05","legal_status":"Granted"} US9987262B2 05 Jun, 2018 Granted 14 Nov, 2034
{"application_id":"18591","ingredient":"VADADUSTAT","trade_name":"VAFSEO","family_id":"e14e7118e981465fa4fa","publication_number":"US11065237B2","cleaned_patent_number":"11065237","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-14","publication_date":"2021-07-20","legal_status":"Granted"} US11065237B2 Molecular Formulation 20 Jul, 2021 Granted 14 Nov, 2034
{"application_id":"18584","ingredient":"VADADUSTAT","trade_name":"VAFSEO","family_id":"e14e7118e981465fa4fa","publication_number":"US10149842B2","cleaned_patent_number":"10149842","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-14","publication_date":"2018-12-11","legal_status":"Granted"} US10149842B2 Molecular Formulation 11 Dec, 2018 Granted 14 Nov, 2034
{"application_id":"18582","ingredient":"VADADUSTAT","trade_name":"VAFSEO","family_id":"e14e7118e981465fa4fa","publication_number":"US9701636B2","cleaned_patent_number":"9701636","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-14","publication_date":"2017-07-11","legal_status":"Granted"} US9701636B2 Molecular Formulation 11 Jul, 2017 Granted 14 Nov, 2034
{"application_id":"18179","ingredient":"VADADUSTAT","trade_name":"VAFSEO","family_id":"8d64e71b3fe74519bc0a","publication_number":"US11324734B2","cleaned_patent_number":"11324734","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-03-31","publication_date":"2022-05-10","legal_status":"Patented case"} US11324734B2 Formulation 10 May, 2022 Patented case 31 Mar, 2036
{"application_id":"111106","ingredient":"VADADUSTAT","trade_name":"VAFSEO","family_id":"8d64e71b3fe74519bc0a","publication_number":"US11844756B2","cleaned_patent_number":"11844756","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-03-31","publication_date":"2023-12-19","legal_status":"Granted"} US11844756B2 19 Dec, 2023 Granted 31 Mar, 2036

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Vadadustat

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.